Article Menu

Export Article

More by Authors Links

Article Data

  • Views 1332
  • Dowloads 151

Case Report

Open Access

Macrophage activation syndrome in a child with systemic onset of juvenile idiopathic arthritis

  • BARBARA STANIMIROVIĆ1
  • STOJISLAV KONJEVIĆ1
  • BILJANA ĐURĐEVIĆ-BANJAC1
  • DARIO ĐUKIĆ1
  • DEJAN PEJIĆ2
  • JELENA MRĐA3

1Clinic of Paediatrics, University Hospital Clinical Centre, Banja Luka, Bosnia and Herzegovina

2General Hospital Gradiška, Gradiška, Bosnia and Herzegovina

3Clinic of Internal Medicine, University Hospital, Clinical Centre, Banja Luka, Bosnia and Herzegovina

DOI: 10.22514/SV101.062015.15 Vol.10,Issue S1,June 2015 pp.55-57

Published: 22 June 2015

*Corresponding Author(s): BARBARA STANIMIROVIĆ E-mail: barbarastanimirovic@gmail.com

PDF (93.31 kB) View Full-text

Abstract

Macrophage activation syndrome (MAS) is a serious and potentially fatal complica-tion of various diseases, mainly systemic in-flammatory connective tissue disorders, the most frequent being systemic juvenile idi-opathic arthritis (sJIA). Its most important clinical and laboratory manifestations are non-remitting fever, hepatosplenomegaly, impaired liver function, cytopenia, hypoal-buminemia, hypertriglyceridemia, hypofi-brinogenemia and hyperferritinemia. The prognosis for the syndrome is often poor, so a prompt diagnosis and the appropriate medical treatment are critical for survival. We report a case of an 8-year-old boy who developed MAS as a complication of sJIA. The boy presented with liver insufficiency, impaired coagulation, encephalopathy and respiratory failure and was treated in in-tensive care unit (ICU). He has achieved complete remission of the disease after ther-apy with pulse doses of corticosteroids and ciclosporin.

Keywords

macrophage activation syndrome, rheumatic diseases, haemophagocytic lym-phohistiocytosis

Cite and Share

BARBARA STANIMIROVIĆ,STOJISLAV KONJEVIĆ,BILJANA ĐURĐEVIĆ-BANJAC,DARIO ĐUKIĆ,DEJAN PEJIĆ,JELENA MRĐA. Macrophage activation syndrome in a child with systemic onset of juvenile idiopathic arthritis. Signa Vitae. 2015. 10(S1);55-57.

URL:

https://www.signavitae.com/articles/10.22514/SV101.062015.15

References

1. Cassidy JT, Petty RE, Laxer RM, Lindsley CB. Textbook of pediatric rheumatology: macrophage activation syndrome,45, 6th ed. Elsevier Saunders; 2011. p. 674–81.

2. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421-6.

3. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol. 2002;14:548-52.

4. Ravelli A, Magni-Manzoni A, Pistorio A, Besana C, Foti T,Ruperto N, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr. 2005;146:598–604.

5. Emmenegger U, Reimers A, Frey U, et al. Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation. Swiss Med Wkly 2002; 132: 230-236.

6. Weitzman S. Approach to hemophagocytic syndromes. AmSoc Hematol. 2011;1:178–83.9

7. Stephan JL, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology 2001; 40: 1285-1292.

8. Ravelli A, Caria MC, Buratti S, Mulattia C, Temporini F, MartiniA. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol. 2001;28:865-7

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

Top